Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
212 hedge funds and large institutions have $320M invested in Immunogen Inc in 2019 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 32 closing their positions.
38% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 32
26% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $10.3M
19% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 54
6% more funds holding
Funds holding: 200 → 212 (+12)
46% less capital invested
Capital invested by funds: $589M → $320M (-$269M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$19.7M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$9.44M |
| 3 |
QF
QVT Financial
New York
|
+$5.96M |
| 4 |
DAM
DLD Asset Management
New York
|
+$5.14M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$20.5M |
| 2 |
Millennium Management
New York
|
-$13.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.99M |
| 5 |
Morgan Stanley
New York
|
-$8.75M |
IMGN Hedge Fund Activity: Q1 2019 in Review
212 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2019, worth a combined $320M — down 46% from $589M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IMGN positions and 32 closed out — a net gain of 12 holders — while 64 added to existing stakes and 54 trimmed.
The largest buyer was State Street, adding an estimated $19.7M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.
- 212 institutional investors held Immunogen Inc (IMGN) as of Q1 2019, up from 200 in Q4 2018.
- Funds reported $320M of Immunogen Inc stock for Q1 2019, down 46% quarter-over-quarter.
- 44 funds opened new Immunogen Inc positions in Q1 2019 and 32 closed out, a net change of +12 holders.
- The largest Immunogen Inc buyer in Q1 2019 was State Street, an estimated $19.7M added.
- The largest Immunogen Inc seller in Q1 2019 was Fidelity Investments, an estimated $20.5M sold.
Based on aggregated 13F filings for Q1 2019.